Finzati - Logo
CLB logo

Core Laboratories N.V.

CLBOil & Gas Equipment & Services
$12.54
+0.01 (+0.08%)
Current price
EarningsLatest report: Jun 30, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$587.85M
Growth
5.9%
Cash Flow
5/5
Trend
Stable
Evidence
Positive free cash flow · 0.49Consistent free cash flow · 5/5Manageable debt level · 0.74Healthy liquidity · 2.07Negative growth trend
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$12.54
Change0.08%
Shares Out46.88M
Market Cap$587.85M
Enterprise Value$604.43M
52W Range9.72 - 20.36
Beta1.01
P/E24.14
P/S1.13
P/B2.11
P/FCF22.27
EV/Sales1.16

Investment DNA

How strong this company looks for long-term investors

61
out of 100
Business Quality
Margins, moat, returns
54/100
Financial Strength
Debt, cash, stability
80/100
Growth Potential
Revenue and expansion
37/100
Price Attractiveness
Cheap or expensive today
68/100
Why this score
Positive free cash flow · 0.49Consistent free cash flow · 5/5Manageable debt level · 0.74Healthy liquidity · 2.07Negative growth trend

Analyst view

Analyst sentiment and price target

CLB
Analyst sentiment
Based on 37 analyst votes · 2026-09-05
66/100
Neutral
Bullish
16
Hold
17
Bearish
4
Price Target
2026-07-31
Low
$17.00
Mean
$25.00
Median
$26.00
High
$32.00

Company Overview

IPO: 9/21/1995
Industry: Oil & Gas Equipment & Services
P/B i: 2.11
Debt / Equity i: 0.74
Operating Margin: 9.59%
Net Margin: 5.63%
ROE i: -
ROIC: -

Financial Health

Score16 / 20
Debt / Equity: 0.74
Current Ratio: 2.07
Quick Ratio: 1.57
Status: Strong

Insider Transactions

Recent executive and insider activity

1 high-volume insider sell detected
Tattoli Mark Damian
Transaction: 05/01/2026
SELL
Change
-250
Price
Not reported
Filing
05/04/2026
Type
SELL
Tattoli Mark Damian
Transaction: 05/01/2026
SELL
Change
-97
Price
$14.07
Filing
05/04/2026
Type
SELL
Murray Katherine
Transaction: 04/01/2026
SELL
Change
-8,069
Price
Not reported
Filing
04/08/2026
Type
SELL